Lipoprotein(a) [Lp(a)] Assay

Lp(a) is intended as a latex particle enhanced immunoturbidimetric assay for the in vitro quantitative determination of lipoprotein(a) [Lp(a)] concentration in human serum or plasma (EDTA) on clinical chemistry systems.

Regulatery Status: FDA 510(k), CE

Product Catalog Number Packaging Method/Format
Product Catalog No: Kit (300 Tests) Pack Size: DZ131A-K Pack Size: R1: 1 x 60 mL
R2: 1 x 20 mL
Pack Size: Latex Enhanced Immunoturbidimetric Assay Liquid Stable
Product Catalog No: Kit (300 Tests) Pack Size: DZ131A-KB1 Pack Size: R1: 1 x 60 mL
R2: 1 x 20 mL
Product Catalog No: Kit (300 Tests) Pack Size: DZ131A-KY1 Pack Size: R1: 1 x 60 mL
R2: 1 x 20 mL
Product Catalog No: Calibrator Pack Size: DZ131A-CAL Pack Size: Cal: 5 x 1 mL vial
Pack Size:
Product Catalog No: Control Pack Size: DZ131A-CON Pack Size: Con: 2 x 1 mL vial
Product Catalog No: Control Pack Size: DZ138A-CON Pack Size: Con: 3 x 3 mL vial

Category:
Product Features

Lp(a) is a dual liquid stable reagent system which provides reliable results and is offered with time saving instrument specific packaging options which eliminate reagent transfer and increase operator efficiency. Instrument specific packaging options including RocheTM Hitachi 917 series, Beckman AU (400/600/640/680), Beckman Synchron CX, LX and DXC. The method requires only 6 μl of serum sample completed in less than 10 minutes and has excellent correlation with existing commercial products with r2 of 0.998, slope of 0.99, and y intercept of 0.03. The assay has intra precision values of less than 2.6%.

Assay Principle

Lp(a) Assay is based on a latex enhanced immunoturbidimetric method. Lp(a) in the sample binds to the specific anti-Lp(a) antibody, which is coated on latex particles, and causes agglutination. The degree of the turbidity caused by agglutination can be measured optically and is proportional to the amount of Lp(a) in the sample.

Order Enquiry

Order Enquiry Form

Enquiry